ENDRA Life Sciences (NDRA) Long-Term Debt Issuances: 2016-2019
Historic Long-Term Debt Issuances for ENDRA Life Sciences (NDRA) over the last 1 years, with Sep 2019 value amounting to $2.5 million.
- ENDRA Life Sciences' Long-Term Debt Issuances was N/A to $2.5 million in Q3 2019 from the same period last year, while for Sep 2019 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2019, which is 166.28% up from last year.
- According to the latest figures from Q3 2019, ENDRA Life Sciences' Long-Term Debt Issuances is $2.5 million, which was up 166.28% from $935,300 recorded in Q2 2018.
- In the past 5 years, ENDRA Life Sciences' Long-Term Debt Issuances ranged from a high of $2.5 million in Q3 2019 and a low of -$132,000 during Q4 2016.
- Moreover, its 3-year median value for Long-Term Debt Issuances was $935,300 (2018), whereas its average is $1.2 million.
- Data for ENDRA Life Sciences' Long-Term Debt Issuances shows a peak YoY spiked of 350.00% (in 2017) over the last 5 years.
- ENDRA Life Sciences' Long-Term Debt Issuances (Quarterly) stood at -$132,000 in 2016, then soared by 350.00% to $225,000 in 2017, then reached $935,300 in 2018, then reached $2.5 million in 2019.
- Its Long-Term Debt Issuances was $2.5 million in Q3 2019, compared to $935,300 in Q2 2018 and $225,000 in Q1 2017.